3068 POSTER Capecitabine + irinotecan + bevacizumab as first-line therapy for patients (pts) with metastatic colorectal cancer (MCRC): preliminary phase II study results
2007 ◽
Vol 5
(4)
◽
pp. 256-257
Keyword(s):
Phase Ii
◽
2001 ◽
Vol 37
◽
pp. S272
◽